AG真人官方

Goldman Sachs BDC, Inc. (NYSE: GSBD) filed a Form 8-K to inform investors of its second-quarter 2025 reporting timetable. The company will release results for the period ended 30 June 2025 after the market closes on Thursday, 7 August 2025, and will host an earnings conference call on Friday, 8 August 2025 at 9:00 a.m. ET. The disclosure is furnished under Item 7.01 (Reg FD) and therefore is not considered 鈥渇iled鈥� for Exchange Act liability purposes. No preliminary financial figures, guidance, or additional operational details were included. Exhibit 99.1 contains the corresponding press release; Exhibit 104 provides the Inline XBRL cover data.

Masco Corporation (MAS) Form 4 discloses that President & CEO Jonathon Nudi increased his beneficial ownership on 07/07/2025.

• Common stock: 17,150 shares acquired at $0.0000, raising direct holdings to 22,750 shares.
• Employee stock options: 54,260 options granted at an exercise price of $65.30, vesting in three equal tranches on 02/13/2026, 02/13/2027 and 02/13/2028, expiring 02/13/2035, issued under the 2024 Long-Term Stock Incentive Plan.

No shares were sold; all reported transactions increase the insider鈥檚 stake, suggesting strengthened alignment between management incentives and shareholder interests.

National Vision Holdings (EYE) Form 4 filing: On 07/08/2025, Mark Banner, President of the America鈥檚 Best segment, converted 11,728 restricted stock units (RSUs) into common stock (transaction code M). To satisfy withholding taxes, 3,462 shares were surrendered at $24.73 (code F), resulting in a net increase of 8,266 directly owned shares. Banner now directly holds 8,266 common shares and still has 64,575 unvested RSUs scheduled to vest in equal installments over the next two years. The gross value of the withheld shares is roughly $204 k, making this a routine equity-settled award rather than an open-market transaction.

Canadian Imperial Bank of Commerce (CM) has launched a preliminary prospectus supplement for a new Additional Tier 1 capital instrument: the Fixed-Rate Reset Limited Recourse Capital Notes (LRCNs) Series 7 due 2085, and the related Non-Cumulative 5-Year Fixed-Rate Reset Class A Preferred Shares Series 62.

• Structure. Each US$1,000 note is backed by a matching preferred share held in a Limited Recourse Trust. Upon any non-payment, maturity, early redemption, default or regulator-defined 鈥淭rigger Event,鈥� holders鈥� sole remedy is delivery of the trust assets, initially the preferred shares, which may convert into common shares under non-viability contingent capital (NVCC) rules.
• Coupon profile. The notes pay a fixed rate for the first five years (rate not yet set) and thereafter reset every five years to the then-current U.S. Treasury rate plus a spread (also TBD). Interest is payable quarterly and is expressly non-deferrable; a missed payment triggers transfer of the trust assets (鈥淔ailed Coupon Payment Date鈥�).
• Capital treatment. OSFI is expected to recognize the notes as 鈥淎dditional Tier 1鈥� capital, enhancing CIBC鈥檚 regulatory capital base without immediate common-share dilution.
• Subordination. The LRCNs rank below deposit liabilities and senior/subordinated debt. In insolvency or wind-up, noteholders stand only ahead of common and preferred equity, and even that claim is effectively replaced by the trust assets once a Recourse Event occurs.
• Redemption. CIBC may redeem the notes (in whole or part) on the initial reset date and every fifth anniversary thereafter, or in full upon a tax or regulatory event, subject to OSFI approval, at 100% of principal plus accrued interest. A redemption of the underlying preferred shares automatically triggers redemption of an equal amount of notes.
• Market & listing. No exchange listing is planned for either the notes or the preferred shares, and CIBC does not intend to create a trading market. Any common shares issuable after a Trigger Event are expected to be listed on the NYSE and TSX.
• Risk highlights. Investors face limited remedies, potential conversion into equity during stress, subordination, early-call risk, and liquidity constraints. The prospectus includes an extensive risk-factor section beginning on page S-14.

Viking Holdings Ltd (VIK) 鈥� Form 144 overview: The filing discloses that insider Jeffrey Dash has notified the SEC of his intent to sell up to 25,000 ordinary shares of Viking Holdings through broker Morgan Stanley Smith Barney LLC. The proposed sale, scheduled for 01 July 2025, carries an aggregate market value of $1.33 million, based on prevailing market prices. Viking currently has 314,950,576 shares outstanding; the new sale therefore represents roughly 0.008 % of total shares.

Recent 10b5-1 activity: The same account has conducted four 10b5-1 sales in the last three weeks, totaling 150,000 shares for gross proceeds of $7.33 million (06/12/2025鈥�06/26/2025). Including the newly noticed shares, cumulative planned and completed sales over the period reach 175,000 shares, or about 0.055 % of shares outstanding.

Key contextual points for investors:

• The filing is solely a notice of intention; the sale may or may not occur, but the insider must file if the sale could exceed Rule 144 thresholds.
• Sales are being made under a pre-arranged Rule 10b5-1 plan, which can mitigate concerns of trading on undisclosed information.
• The dollar amounts are modest relative to Viking鈥檚 equity base, yet a pattern of insider liquidation鈥攅ven in small increments鈥攃an influence sentiment, particularly for newly public or thinly traded stocks.

On 06/30/2025, IBM filed a Form 4 showing that director Andrew N. Liveris converted a portion of his board fees into 331 鈥淧romised Fee Shares鈥� under the company鈥檚 Deferred Compensation and Equity Award Plan. The transaction is coded "A" (acquisition) and carries a notional valuation reference of $294.78 per underlying share, but no cash was paid; the shares will be distributed only after the director retires. As a result, Liveris鈥� total beneficial ownership increases to 42,008 IBM common shares. The filing involves less than 0.0004 % of IBM鈥檚 ~920 million shares outstanding, entails no open-market activity, and has no immediate effect on share count, cash flow, or corporate control. Overall, the disclosure is a routine, compensation-related insider acquisition with negligible financial or strategic impact on the company.

Ford Motor Company (symbol: F) has filed a Form 144 indicating the proposed sale of 30,000 common shares under Rule 144 of the Securities Act of 1933. The shares will be sold through UBS Financial Services, Inc., 11 Madison Ave., New York, NY 10010, with an aggregate market value of $330,000. The approximate sale date disclosed is 07/01/2025, and the shares are to be listed on the NYSE.

The filing shows that the seller originally acquired the shares via three restricted-stock unit (RSU) vesting events on 03/02/2021 (5,424 shares), 03/04/2022 (13,949 shares) and 03/04/2024 (10,627 shares), matching the total of 30,000 shares to be sold. Ford鈥檚 total shares outstanding, as referenced in the filing, are 3,905,696,769; therefore, the proposed sale represents roughly 0.0008 % of shares outstanding鈥攁n immaterial fraction from a market-capitalization standpoint.

No prior sales were reported during the last three months, and no remarks or 10b5-1 plan adoption dates were disclosed. The filer has affirmed that he or she is not in possession of undisclosed material adverse information.

Investment take-away: While the notice signals insider intent to liquidate equity worth $330,000, the volume is negligible relative to Ford鈥檚 float and should not, by itself, influence the valuation or liquidity of Ford shares.

FormFactor Inc. (FORM) has filed a Form 144 notice indicating an intended insider sale of up to 4,000 common shares through Morgan Stanley Smith Barney on or about 01 Jul 2025. Based on the filing鈥檚 stated aggregate market value of $136,106.80, the planned transaction represents roughly 0.005 % of the company鈥檚 77,076,642 shares outstanding, implying minimal ownership dilution or trading-volume impact.

The seller, identified in the past-sales table as Mike Slessor, acquired the shares as performance stock on 19 Jul 2022. The document notes no gift status or non-cash consideration. Within the preceding three months, the same individual sold 8,000 shares in two tranches (01 May 2025 and 02 Jun 2025) for combined gross proceeds of $246,188.80. Adding the upcoming sale would bring the rolling three-month total to 12,000 shares.

The filing contains the standard representation that the seller is not in possession of undisclosed material adverse information and provides no indication of additional planned transactions beyond the stated amount. Given the modest size relative to market float and the routine nature of a Rule 144 filing, immediate financial impact appears limited; however, continued insider selling can sometimes influence investor sentiment.